ClinConnect ClinConnect Logo
Search / Trial NCT06934330

Effect of Tao Calligraphy Meditation and Energized Water on Depression

Launched by SHA RESEARCH FOUNDATION · Apr 11, 2025

Trial Information

Current as of June 03, 2025

Recruiting

Keywords

Unipolar Depression Well Being Sf 36 Quality Of Life Questionnaire Phq 9 Questionnaire Tao Calligraphy Healing Art Chinese Calligraphy Bai 21 Beckman Anxiety Inventory

ClinConnect Summary

This clinical trial is studying whether practicing Tao Calligraphy Meditation and drinking Energized Water can help improve symptoms of Unipolar Depression in adults. Researchers want to find out if these techniques can make people feel better emotionally and improve their overall quality of life. Participants will be divided into two groups: one will practice the meditation and drink the energized water, while the other will not. They will complete three questionnaires at the start of the study, after six weeks, and again at twelve weeks to see if there are any significant changes in their depression and anxiety levels.

To be eligible for the trial, participants must be at least 19 years old and have been diagnosed with Unipolar Depression by a licensed doctor. They should be willing to commit to daily practices of meditation for at least 30 minutes and spend a minimum of five minutes with the energized water. It's important to note that individuals with certain mental health conditions, such as bipolar disorder or schizophrenia, and those who are pregnant or nursing are not eligible for this study. If you join, you will help researchers gather valuable information that may lead to new ways to support people with depression.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age 19 and over with a primary diagnosis as one Unipolar depression according to International Classification of Diseases (ICD)-10 criteria is present and diagnosed by a licensed physician.
  • Willingness and ability to comply with data collection requirements
  • Submission of required documentation before entering the study, including informed consent and consent to release of information
  • Willingness to allow their data to be used for research purposes and published as deemed fit (while conforming to all applicable privacy laws) by Sha Research Foundation
  • Willingness to practice the daily mindfulness practices for at least 30 minutes and follow the study protocol
  • Exclusion Criteria:
  • Not meeting any of the inclusion criteria
  • Bipolar disorders, schizophrenia (psychosis)
  • Treatment with highly potent neuroleptics
  • Unwillingness to participate in data gathering
  • Unable to follow the practice regimen, including the daily individual mindfulness practices for at least 30 minutes
  • Pregnant or nursing. Participants who become pregnant during the study will be required to end their participation.
  • Serious mental disorders (e.g., schizophrenia)
  • There is no exclusion criteria placed upon potential subjects related to national origin, culture, ethnicity, race, sex, physical disability, sexual orientation, religion, or spiritual practices.

About Sha Research Foundation

SHA Research Foundation is a dedicated clinical trial sponsor committed to advancing medical research and innovation through rigorous scientific inquiry. By fostering collaboration among researchers, healthcare professionals, and industry partners, SHA Research Foundation aims to facilitate the development of novel therapies and improve patient outcomes. With a focus on ethical practices and patient-centered approaches, the foundation seeks to address unmet medical needs across various therapeutic areas, ensuring that the insights gained from clinical trials translate into meaningful advancements in healthcare.

Locations

Kahului, Hawaii, United States

Patients applied

0 patients applied

Trial Officials

Peter Hudoba De Badyn, MD, FRCS,

Principal Investigator

Sha Research Foundation

Laurie Omuro-Yamamoto, PhD

Principal Investigator

Satori Family Wellness Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported